Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 121,607,480
  • Shares Outstanding, K 258,053
  • Annual Sales, $ 9,869 M
  • Annual Income, $ 3,620 M
  • 60-Month Beta 0.39
  • Price/Sales 12.26
  • Price/Cash Flow 31.98
  • Price/Book 6.53
Trade VRTX with:

Options Overview Details

View History
  • Implied Volatility 22.53% ( -1.34%)
  • Historical Volatility 18.94%
  • IV Percentile 26%
  • IV Rank 29.23%
  • IV High 34.35% on 01/16/24
  • IV Low 17.64% on 05/16/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 1,008
  • Volume Avg (30-Day) 1,619
  • Put/Call OI Ratio 1.12
  • Today's Open Interest 37,113
  • Open Int (30-Day) 42,543

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 3.67
  • Number of Estimates 10
  • High Estimate 3.96
  • Low Estimate 3.22
  • Prior Year 3.53
  • Growth Rate Est. (year over year) +3.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
453.73 +4.42%
on 06/03/24
486.42 -2.60%
on 06/07/24
+18.44 (+4.05%)
since 05/31/24
3-Month
391.01 +21.17%
on 04/18/24
486.42 -2.60%
on 06/07/24
+64.36 (+15.72%)
since 04/02/24
52-Week
335.82 +41.08%
on 07/07/23
486.42 -2.60%
on 06/07/24
+121.87 (+34.63%)
since 06/30/23

Most Recent Stories

More News
Bull Market Buys: 2 Growth Stocks to Own for the Long Run

The latest bull market has plenty of intriguing buying opportunities.

COMP : 3.53 (+5.06%)
VRTX : 473.78 (+0.54%)
OKTA : 93.61 (-0.99%)
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now

Growth stocks with wide moats and strong financials can compound investor returns with time.

VRTX : 473.78 (+0.54%)
SPOT : 315.55 (+0.54%)
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

These healthcare stocks have clear paths to growth over the next few years.

LLY : 906.71 (-0.84%)
NVO : 142.98 (-1.68%)
VRTX : 473.78 (+0.54%)
VKTX : 51.54 (-6.83%)
TMDX : 148.97 (-0.81%)
2 Healthcare Stocks That Are Screaming Buys in June

These top healthcare stocks are no-brainer buys in 2024 and beyond.

VRTX : 473.78 (+0.54%)
PFE : 27.83 (-1.38%)
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."

The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.

CRSP : 53.12 (-1.55%)
VRTX : 473.78 (+0.54%)
Is Biogen Stock Underperforming the Nasdaq?

Biogen underperforms the Nasdaq Composite, and analysts remain cautiously optimistic about the stock’s prospects.

BIIB : 228.82 (-1.27%)
$NASX : 18,028.76 (+0.84%)
VRTX : 473.78 (+0.54%)
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?

It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes.

WFC : 60.97 (+0.63%)
VRTX : 473.78 (+0.54%)
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead

Lilly is a good pick...but this one is better.

LLY : 906.71 (-0.84%)
VRTX : 473.78 (+0.54%)
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation

Evergreen business models make it easier to hold for the long run.

VRTX : 473.78 (+0.54%)
COST : 859.36 (+1.62%)
AAPL : 220.27 (+1.62%)
3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Want peace of mind about your investments? Consider these great stocks.

LLY : 906.71 (-0.84%)
NVO : 142.98 (-1.68%)
VRTX : 473.78 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 489.19
2nd Resistance Point 483.56
1st Resistance Point 478.67
Last Price 473.78
1st Support Level 468.15
2nd Support Level 462.52
3rd Support Level 457.63

See More

52-Week High 486.42
Last Price 473.78
Fibonacci 61.8% 428.89
Fibonacci 50% 411.12
Fibonacci 38.2% 393.35
52-Week Low 335.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar